Contact the publisher of this press release
Vesalio Announces FDA Approval of the NeVa VS™ to Treat Cerebral Vasospasm After Aneurysmal Rupture
Vesalio Announces FDA Approval of the NeVa VS™ to Treat Cerebral Vasospasm After Aneurysmal Rupture